Comment on Mizokami-Stout et al. The Contemporary Prevalence of Diabetic Neuropathy in Type 1 Diabetes: Findings From the T1D Exchange. Diabetes Care 2020;43:806–812

Benzer Materyaller

• Response to Comment on Mizokami-Stout et al. The Contemporary Prevalence of Diabetic Neuropathy in Type 1 Diabetes: Findings From the T1D Exchange. Diabetes Care 2020;43:806–812
  Yazar:: Mizokami-Stout, Kara R., ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Comment on Piccinini and Bergman. The Measurement of Insulin Clearance. Diabetes Care 2020;43:2296–2302
  Yazar:: Gastaldelli, Amalia, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Response to Comment on Piccinini and Bergman The Measurement of Insulin Clearance. Diabetes Care 2020;43:2296–2302
  Yazar:: Bergman, Richard N., ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Comment on Löndahl. Number Eight in the Service of Diabetic Foot Ulcer Healing. Diabetes Care 2020;43:515–517
  Yazar:: Frykberg, Robert G.
  Baskı/Yayın Bilgisi: (2020)
• Comment on Flory et al. Reports of Lactic Acidosis Attributed to Metformin, 2015–2018. Diabetes Care 2020;43:244–246
  Yazar:: Brand, Kerstin
  Baskı/Yayın Bilgisi: (2020)